NCT00174239 - Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease. | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

September 30, 2005

Conditions

Parkinson Disease

Interventions

DRUG

cabergoline

DRUG

controlled-release levodopa / carbidopa

Trial Locations (14)

Pfizer Investigational Site, Westmead

Pfizer Investigational Site, Brisbane

Pfizer Investigational Site, Loc. Camerelle - Pozzilli

Pfizer Investigational Site, Vittoria

Pfizer Investigational Site, Bologna

Pfizer Investigational Site, Bolzano

Pfizer Investigational Site, Napoli

Pfizer Investigational Site, Padua

Pfizer Investigational Site, Palermo

Pfizer Investigational Site, Roma

Pfizer Investigational Site, Barcelona

Pfizer Investigational Site, Madrid

Pfizer Investigational Site, Oviedo

Pfizer Investigational Site, Seville